Drug intelligence / Profile preview

ABO- and Rh-compatible whole blood

Development stage
Unknown
Lead developer
Xijing Hospital
Modality
Cell Therapies
Administration
Intravenous
01

Overview

ABO- and Rh-compatible whole blood is a transfusion product consisting of un-fractionated human blood that has been matched to the recipient's ABO and Rhesus (Rh) blood group systems. In the clinical trial conducted by Xijing Hospital, this intervention is utilized for the emergency resuscitation of patients suffering from hemorrhagic shock due to trauma or gastrointestinal bleeding. Unlike component therapy, which separates blood into red blood cells, plasma, and platelets, whole blood provides these elements in their natural physiological ratios, aiming to improve oxygen delivery and hemostatic function while reducing the volume of anticoagulants and additives administered. The trial evaluates its efficacy, timeliness, and safety compared to standard massive transfusion protocols and low-titer group O whole blood.

Other names
type-specific whole bloodABO-compatible whole bloodRh-compatible whole blood

Beyond the preview

Go deeper on ABO- and Rh-compatible whole blood.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABO- and Rh-compatible whole blood.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call